Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00794976 · ClinicalTrials.gov registry record · Phase 2
Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis
A Phase 2 study of Lateral Epicondylitis and Tennis Elbow, sponsored by Travanti Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 216
- Enrollment target
- 10
- Study locations
NCT00794976: Completed Phase 2 study of Lateral Epicondylitis and Tennis Elbow, sponsored by Travanti Pharma.
NCT00794976 is a Phase 2 study of Lateral Epicondylitis and Tennis Elbow that has completed, run by Travanti Pharma. The registered enrollment target is 216 participants, above the 97-participant average among 7 other Lateral Epicondylitis trials with a reported enrollment target (123% higher). The trial reports 10 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00794976, a Phase 2 study of Lateral Epicondylitis and Tennis Elbow, has completed, sponsored by Travanti Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 216 participants
- Enrollment target
- 10
- Study locations
Study Summary
The objective of this study is to determine the safety and efficacy of a dexamethasone iontophoretic transdermal patch for the treatment of pain associated with lateral epicondylitis (tennis elbow).
Conditions Studied
Interventions
- DRUG Placebo Patch
- DRUG Dexamethasone Iontophoretic Patch (low dose)
- DRUG Dexamethasone Iontophoretic Patch (high dose)
- DRUG Dexamethasone Passive Patch
Study Locations (10)
Arizona
- - Phoenix
- - Tucson
Alabama
- - Birmingham
California
- - San Diego
Colorado
- - Steamboat Springs
Florida
- - Tampa
Oklahoma
- - Oklahoma City
South Carolina
- - Columbia
Texas
- - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
What the finished NCT00794976 record still lists
NCT00794976 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, above the 97-participant average among 7 other Lateral Epicondylitis trials with a reported enrollment target (123% higher).
The record links to 2 conditions, with Lateral Epicondylitis appearing as the primary indexed condition, and to 4 interventions - of which Placebo Patch is the first listed.
NCT00794976 lists 10 locations in 9 states (Arizona, Alabama, California).
Frequently Asked Questions
What is clinical trial NCT00794976 about?
NCT00794976 is a clinical study titled "Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis". The objective of this study is to determine the safety and efficacy of a dexamethasone iontophoretic transdermal patch for the treatment of pain associated with lateral epicondylitis (tennis elbow).
What is the current status of trial NCT00794976?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 216 participants. The study started on 2008-10. Estimated completion is 2009-05.
What conditions does trial NCT00794976 study?
This clinical trial studies the following conditions: Lateral Epicondylitis, Tennis Elbow.
What interventions are being tested in trial NCT00794976?
The interventions under investigation include: Placebo Patch (DRUG), Dexamethasone Iontophoretic Patch (low dose) (DRUG), Dexamethasone Iontophoretic Patch (high dose) (DRUG), Dexamethasone Passive Patch (DRUG).
Who is sponsoring clinical trial NCT00794976?
This trial is sponsored by Travanti Pharma, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00794976 being conducted?
This trial has 10 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lateral Epicondylitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis
COMPLETED · Phase 2
-
Blood Flow Restriction & Tennis Elbow Rehab
RECRUITING · NA
-
Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)
RECRUITING · Phase 4
-
Trial of Blood Flow Restriction Plus Physical Therapy vs. Physical Therapy Alone for Lateral Epicondylitis
ACTIVE NOT RECRUITING · NA
-
Doxycycline for Elbow Tendinopathy
ACTIVE NOT RECRUITING · Phase 1
-
Randomized Trial of Iontophoresis Versus Injection of Corticosteroids for Lateral Epicondylitis
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia